Collegium Pharmaceutical (COLL) Depreciation & Amortization (CF) (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Depreciation & Amortization (CF) of $463000.0 for Q1 2026, down 57.56% year-over-year from $1.1 million in Q1 2025, and down 49.84% quarter-over-quarter from $923000.0 in Q4 2025.
Collegium Pharmaceutical (COLL) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Depreciation & Amortization (CF) history runs 13 years deep, the most recent figure standing at $463000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 57.56% year-over-year to $463000.0; the TTM figure through Mar 2026 stood at $3.6 million (down 11.81% YoY), while the FY2025 annual figure was $4.2 million, up 8.45% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $463000.0, down from $923000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $1.1 million in Q2 2025, with the low at $463000.0 in Q1 2026.
- The 5-year median for Depreciation & Amortization (CF) is $917000.0 (2024), against an average of $863588.2.
- The sharpest annual moves came in 2022 and 2026: Depreciation & Amortization (CF) surged 94.58% in 2022, then sank 57.56% in 2026.
- Collegium Pharmaceutical's Depreciation & Amortization (CF) stood at $825000.0 in 2022, then advanced by 15.03% to $949000.0 in 2023, then increased by 9.69% to $1.0 million in 2024, then decreased by 11.34% to $923000.0 in 2025, then sank by 49.84% to $463000.0 in 2026.
- Business Quant data shows COLL's Depreciation & Amortization (CF) at $463000.0 in Q1 2026, $923000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Collegium Pharmaceutical | 897.87 Mn | 748.55 Mn | 110.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.81 Mn |
| Jun 30, 2026 | 1.81 Mn |
| Mar 31, 2026 | 463,000.00 |
| Mar 31, 2026 | 463,000.00 |
| Dec 31, 2025 | 923,000.00 |
| Dec 31, 2025 | 923,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 946,000.00 |
| Sep 30, 2024 | 946,000.00 |
| Jun 30, 2024 | 952,000.00 |
| Jun 30, 2024 | 952,000.00 |
| Mar 31, 2024 | 917,000.00 |
| Mar 31, 2024 | 917,000.00 |